An experimental model on the protective impact of nanosilymarin on ulcerative colitis induced by TNBS in rats: The inclusion of TLR۴ / NF-κB pathway

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 222

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_NAMJ-9-3_004

تاریخ نمایه سازی: 4 تیر 1401

چکیده مقاله:

Objective(s): The present work aimed to assess the protective impacts of nanosilymarin or silymarin on colitis induced by TNBS in rats. Materials and Methods: Induction of acute colitis was conducted by rectally administering ۲ ml of TNBS solution. About ۲ hr followed by induction of colitis, the rates were given dexamethasone (۲ mg / kg), normal saline, silymarin (۵۰, ۱۰۰, and ۲۰۰ mg / kg), and nanosilymarin (۵۰,۱۰۰, and ۲۰۰ mg / kg) orally for two weeks. Damage was assessed at the macroscopic and microscopic levels. MPO enzyme activity was measured using biochemical technique and also ELISA kit was used to measure tissue levels of TNF-α and IL-۱β and Western blot analysis was utilized to study the expression level of P۶۵ TLR۴ and pNF-κB proteins. According to the results, dexamethasone (۲ mg / kg) and nanosilimarin (۲۰۰ mg / kg) reduced tissue damages than the TNBS group (P<۰.۰۰۱). Moreover, these drugs reduced MPO activity (P<۰.۰۰۱) and levels of TNF-α and IL-۱β (P<۰.۰۰۱) in colon tissue than the TNBS group and also the expression of p۶۵ TLR۴ and pNF-κB proteins was decreased when in comparison to the TNBS group.Conclusion: It is proposed that nanosilimarin reduce colon inflammation in TNBS-induced experimental colitis by inhibition of the TLR۴ / NFκB molecular path.

کلیدواژه ها:

نویسندگان

Mohsen Hoseini

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Sina Mohammadi

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Amirabas Mohammadi-hamaneh

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Tina Akbarzadeh

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Alireza Abdollahi

Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Mahmoud Reza Jaafari

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Seyyedeh Elaheh Mousavi

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Amir Rashidian

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Seyed Mahdi Rezayat

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Sinopoulou V, Gordon M, Dovey TM, Akobeng AK. Interventions for ...
  • Rashidian A, Dejban P, Karami Fard K, Abdollahi A, Chamanara ...
  • Goyal N, Rana A, Ahlawat A, Bijjem KR, Kumar P. ...
  • Aderem A, Ulevitch RJ. Toll-like receptors in the induction of ...
  • Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A. ...
  • Rashidian A, Muhammadnejad A, Dehpour A-R, Mehr SE, Akhavan MM, ...
  • Aderem A. Role of Toll-like receptors in inflammatory response in ...
  • Jafari RM, Shayesteh S, Ala M, Yousefi-Manesh H, Rashidian A, ...
  • Lovelace ES, Wagoner J, MacDonald J, Bammler T, Bruckner J, ...
  • Mombeini M, Saki G, Khorsandi L, Bavarsad N. Effects of ...
  • Javed S, Kohli K, Ali M. Reassessing bioavailability of silymarin. ...
  • Sohrabi MJ, Dehpour A-R, Attar F, Hasan A, Mohammad-Sadeghi N, ...
  • Rashidian A, Roohi P, Mehrzadi S, Ghannadi AR, Minaiyan M. ...
  • Bou-Fersen AM, Anim JT, Khan I. Experimental colitis is associated ...
  • Molodecky NA, Soon S, Rabi DM, Ghali WA, Ferris M, ...
  • Dou W, Zhang J, Sun A, Zhang E, Ding L, ...
  • Scheiffele F, Fuss IJ. Induction of TNBS colitis in mice. ...
  • Atreya I, Atreya R, Neurath M. NF‐κB in inflammatory bowel ...
  • Colitis-Pathophysiology U. Inflammatory bowel disease part I: ulcerative colitis-pathophysiology and ...
  • Surai PF. Silymarin as a natural antioxidant: an overview of ...
  • Fallah M, Davoodvandi A, Nikmanzar S, Aghili S, Mirazimi SMA, ...
  • Mohsin RH, Al-Zamely HA. Treatment of induced diabetes in rats ...
  • نمایش کامل مراجع